BiotechTube
Home/NervGen Pharma/Paul Brennan
PB

Paul Brennan

President & Chief Executive Officer, Director

NervGen Pharma

Therapeutic Areas

NeurologyNeurodegenerative DiseasesNeurotrauma

NervGen Pharma Pipeline

DrugIndicationPhase
NVG-291Spinal Cord InjuryPhase 1b/2a

Leadership Team at NervGen Pharma

W(
William (Bill) Radvak
Executive Chairman
DM
Daniel Mikol
Chief Medical Officer
MK
Michael Kelly
Chief Financial Officer
MT
Matthew Thatcher
Chief Scientific Officer
AH
Allan Hindmarsh
VP, Pharmaceutical Sciences
MR
Michele Rusnak
VP, Regulatory & Quality Assurance
JR
John Ruffolo
Director
JA
John A. B. (JAB) Young
Director
JA
Jane A. Gross
Director
JS
Jerry Silver
Scientific Advisory Board Member
View full NervGen Pharma profile